The IFN-λ Family (IL-28/29)

ISSN: 1875-614X (Online)
ISSN: 1871-5230 (Print)

Volume 16, 3 Issues, 2017

Download PDF Flyer

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Claudiu T. Supuran
Neurofarba Department
University of Florence

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

The IFN-λ Family (IL-28/29)

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 5(3): 279-285.

Author(s): Sergei V. Kotenko and Raymond P Donnelly.

Affiliation: Department of Biochemistry and Molecular Biology, University of Medicine and Dentistry (UMDNJ) -New Jersey Medical School, New Jersey, USA.


IFN-λs or type III IFNs are also known as IL-28/29. This group of cytokines is the latest addition to the family of cytokines that signal through receptors of the class II cytokine receptor family (CRF2). Although IFN-λs and IFN-α/β (type I IFNs) utilize distinct receptor complexes for signaling, type I and type III IFNs activate the same intracellular signaling pathway and many similar biological activities, including the ability to induce antiviral state in cells. Consistent with their antiviral activity, the expression of IFN-λ mRNAs is inducible by viral an infections. Therefore, IFN-λs functionally resemble type I IFNs, supporting their designation as IFNs. However, IFN- λs also share several common features with cytokines of the IL-10 family that includes IL-19, IL-20, IL-22, IL-24 and IL-26. Their genes have a similar intron-exon structure, they share some sequence homology, and most likely they share a similar structural organization. IFN-λs also share a common receptor subunit, IL-10R2, with IL-10, IL- 22 and IL-26. However, the ligand-binding chain, IFN-λR1, is a unique component of the IFN-λ receptor complex. Although the relative importance of the IFN-λs remains to be fully determined, recent experiments demonstrate their strong potential as antiviral and antitumor therapeutics.


Interferons, interleukins, cytokines, receptors, signal transduction, inflammation, antiviral response.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 5
Issue Number: 3
First Page: 279
Last Page: 285
Page Count: 7
DOI: 10.2174/187152306778017656
Price: $58
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science